Humacyte

Humacyte's mission is to become a leader in novel, off-the-shelf extracellular matrix tissue products, especially those that could provide life-saving improvements in treatments for vascular conditions. Because Humacyte grows these tissue replacements in vitro from banked vascular cells that are decellularized, its products do not require cells from the patient and can be easily stored until patients and their surgeons need them. Founded in 2004, Humacyte is a privately held company led by experts in clinical trials, regulatory affairs, business and commercial development, finance and intellectual property management. Humacyte is headquartered in Morrisville, North Carolina.

Visite el sitio web de Humacyte

Quiénes somos

Participe en el Foro

  • Iniciar sesión
  • Asóciese con nosotros
  • Conviértase en miembro
  • Regístrese para recibir nuestras notas de prensa
  • Suscríbase a nuestros boletines
  • Contacte con nosotros

Enlaces directos

Ediciones en otros idiomas

Política de privacidad y normas de uso

Sitemap

© 2025 Foro Económico Mundial